Drugs / HRS-7156
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07601087 | Jun → Jul 2026 overdue | heart failure | Shandong Suncadia Medicine Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRS-7156 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07601087 ↗ |
| Route | Oral | “Single and Multiple Ascending Oral Doses” NCT07601087 ↗ |